We are a Highly experienced
Health Economics & Outcomes Research Agency
What we do
We identify, evaluate and communicate the value of drugs and devices
Evidence Development
Systematic literature reviews
Rapid and pragmatic literature reviews
Strategic evidence searches
Environmental scans
Health Economic Modelling
Early-stage economic evaluations
Global cost-effectiveness models
Local country adaptations
Budget impact models
Health Technology Assessment
Reimbursement submissions
Advisory boards
Strategy
Statistical Analysis
Network meta-analysis
Matching-adjusted indirect comparison
Trial data analysis
Survival analysis
Publications
Strategic publication planning
Manuscripts for peer review
Poster design and production
Podium presentations
Market Access
Reimbursement strategy
Evidence-based value communication
Key opinion leader engagement
What makes us different
We are a small group of highly experienced researchers with international backgrounds in academia, government and industry. Our deep knowledge and nimble approach allows us to meet your needs with flexibility, technical excellence, timeliness and good humour. We take pride in our work and we get results. We are experts in achieving reimbursement for pharmaceuticals and devices in countries around the world, and communicating value in healthcare to diverse audiences.
rigorous solutions for complex problems
Years in business
From Our Clients
"I have worked with Symmetron on HTAs for NICE and SMC and found the team professional, flexible in responding to my needs and willing to go the extra mile to deliver on our desired outcomes. I look forward to working with them again."
Director of Market Access & External Affairs"Symmetron has led the development of several complex economic models for us over several years and has always delivered rigorous research and rock-solid timely results. All output always stood up to HTA scrutiny and what I admired most is how well Symmetron managed not only the development of the model, but also the KOL alignment meetings. A tremendous pleasure to work with and a relaxing experience."
Director of Global Health Economics and Outcomes Research